Patents/Inventors

Klaus Erb

Ingelheim Am RheinDE9 patents

7 Patents

US125095222025
Polypeptides Comprising Immunoglobulin Single Variable Domains Targeting Il-13 and OX40L
Sanofi
0 cites
US124922482025
Methods of Treatment Utilizing Polypeptides Comprising Immunoglobulin Single Variable Domains Targeting IL-13 and TSLP
Sanofi
0 cites
US124537492025
Recombinant Rhabdovirus Encoding for CCL21
Boehringer Ingelheim International GmbH
0 cites
US123848402025
Nucleic Acids Encoding Polypeptides Comprising Immunoglobulin Single Variable Domains Targeting IL-13 and TSLP
Sanofi
0 cites
US121717952024
Recombinant Rhabdovirus Encoding for a CD80 Extracellular Domain Fc-fusion Protein
Boehringer Ingelheim International GmbH
0 cites
US118405662023
Methods of Treating Asthma with Polypeptides Targeting IL-13 and TSLP
Sanofi
0 cites
US117074952023
Recombinant Rhabdovirus Encoding for CCL21
Viratherapeutics GmbH
0 cites